Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naila Goldenberg

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Metabolism: Clinical and Experimental|January 22, 2009
Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?Charles J Glueck, Bishal Rawal, Naseer Ahmed Khan, et al.
Orthopedics|September 7, 2017
T786C Mutation in the Endothelial Nitric Oxide Synthase Gene in Patients With Primary OsteonecrosisAmir M Khan, Joshua Choi, Richard A Freiberg, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 11, 2017
Progressively Worsening Premature Coronary Artery Disease: Adding Anticoagulation Stabilizes-Reverses Clinical Symptomatic Disease Progression in Thrombophilic-Atherothrombotic Patients: A Pilot StudyMatan Rothschild, Vybhav Jetty, Christopher Mahida, et al.
Metabolism: Clinical and Experimental|March 21, 2006
Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescentsCharles J Glueck, John A Morrison, Lisa Aronson Friedman, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 23, 2008
Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patientsWaqas Ahmed, Naseer Khan, Charles J Glueck, et al.
Current Medical Research and Opinion|July 7, 2011
Vitamin D deficiency, myositis-myalgia, and reversible statin intoleranceCharles J Glueck, Shaaista B Budhani, Silpa S Masineni, et al.
Lipids in Health and Disease|August 20, 2016
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment centerParth Shah, Charles J Glueck, Vybhav Jetty, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fastingAlla A Sakharova, Jeffrey F Horowitz, Sowmya Surya, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 20, 2011
Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophiliaCharles J Glueck, Naila Goldenberg, Shaaista Budhani, et al.
Lipids in Health and Disease|January 25, 2017
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization studyParth Shah, Charles J Glueck, Naila Goldenberg, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Metabolism: Clinical and Experimental|January 22, 2009
Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?Charles J Glueck, Bishal Rawal, Naseer Ahmed Khan, et al.
Orthopedics|September 7, 2017
T786C Mutation in the Endothelial Nitric Oxide Synthase Gene in Patients With Primary OsteonecrosisAmir M Khan, Joshua Choi, Richard A Freiberg, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|April 11, 2017
Progressively Worsening Premature Coronary Artery Disease: Adding Anticoagulation Stabilizes-Reverses Clinical Symptomatic Disease Progression in Thrombophilic-Atherothrombotic Patients: A Pilot StudyMatan Rothschild, Vybhav Jetty, Christopher Mahida, et al.
Metabolism: Clinical and Experimental|March 21, 2006
Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescentsCharles J Glueck, John A Morrison, Lisa Aronson Friedman, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|December 23, 2008
Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patientsWaqas Ahmed, Naseer Khan, Charles J Glueck, et al.
Current Medical Research and Opinion|July 7, 2011
Vitamin D deficiency, myositis-myalgia, and reversible statin intoleranceCharles J Glueck, Shaaista B Budhani, Silpa S Masineni, et al.
Lipids in Health and Disease|August 20, 2016
Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment centerParth Shah, Charles J Glueck, Vybhav Jetty, et al.
The Journal of Clinical Endocrinology and Metabolism|April 17, 2008
Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fastingAlla A Sakharova, Jeffrey F Horowitz, Sowmya Surya, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 20, 2011
Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophiliaCharles J Glueck, Naila Goldenberg, Shaaista Budhani, et al.
Lipids in Health and Disease|January 25, 2017
Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization studyParth Shah, Charles J Glueck, Naila Goldenberg, et al.
Pageof 5